Search
In this October 23, 2020 editorial, which was published in the The American Journal of Managed Care, Michael Abrams explains why drug importation will not save patients money. Abrams is the co-founder and managing partner of Numerof & Associates.
Read More
A summary briefing of 2020’s major cases, worrying trends and a deep dive into drug supply chain policy issues.
Read More
In PSM’s round-up this week: new reports about counterfeit medicine, drug supply chain regulation and phishing scams; FDA warnings about dangerous supplements; a life sentence for fake pill kingpin Aaron Shamo; and more.
Read MoreINTRODUCTION Just as the coronavirus mutates to survive and thrive, so to do the purveyors of counterfeit medicines – with their high-speed “host” being the digi-tization of patient care. The future is now. So, how do we balance moving forward with user-friendly digitization, telemedicine and virtual healthcare delivery while simultaneously recognizing the unintended consequences of the innovative criminal mind? The…
Read MoreIn this analysis, which was published in Lexology on October 13, 2020, three global regulatory experts examine barriers to drug importation.
Read More
In PSM’s round-up this week: Policy truths about drug importation, prosecutions for fake COVID-19 treatments and financial fraud, and another week in counterfeit pills.
Read More
In the first seven months of 2020, the Arizona Department of Health Services reported over 2,700 newly suspected opioid overdose deaths in Arizona. What makes this figure more startling is that there were just over 3,800 suspected opioid deaths in the preceding 30 months. The problem is escalating, and rapidly.
Read More
The editorial board of the Florida Times-Union published an op-ed that states that Canadian drug importation will have a limited impact, and is a sign of a broken system, not a solution to one…
Read More
On February 13, 2020 the Colorado Senate’s Health and Human Services Committee held a hearing during which a member of the committee asked where the $810,000 to implement drug importation has gone, and what the progress is. His questions, which are directed to head of the agency and the lead importation pharmacist, begin at 6:56. Implementing Canadian drug importation has…
Read More
Wyoming is one of many states that decided to examine if importing drugs would provide significant savings to its citizens. In a hearing in August and a report released today, they took a critical look at the issue and the Department of Health recommends that the state not pursue the idea for several key reasons…
Read More